Modulatory effects of proteoglycans on proteinase activities

Methods in Molecular Biology

Volumn 836, Issue , 2012, Pages 307-322

  Georges, Steven ^a,b   Heymann, Dominique ^a,c   Padrines, Marc ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Glycosaminoglycans; Proteinase activities; Proteoglycans

Indexed keywords

PEPTIDE HYDROLASE; PROTEOGLYCAN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; HUMAN; METABOLISM;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; PEPTIDE HYDROLASES; PROTEOGLYCANS;

EID: 84856338340     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-498-8_20     Document Type: Article

References (75)

1. Lamoureux, F.; Baudhuin, M.; Duplomb L, Heymann, D.; Rédini, F. (2007) Proteoglycans: key partners in bone cell biology. BioEssays. 29 , 758-771. (Pubitemid 47204281)
2. Ruiz Velasco, C.; Colliec-Jouault, S.; Rédini, F.; Heymann, D.; Padrines, M. (2010) Proteoglycans on bone tumor development. Drug Discov. Today. 15 , 553-560.
3. Hardingham, T. E. and Fosang, A. J. (1992). Proteoglycans: many forms and many functions. FASEB J. 6 , 861-870.
4. Bernfield, M. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem. 68, 729-777. (Pubitemid 29449208)
5. Barrett, A. J.; Rawlings, N. D.; Woessner, J. F. (2004) The Handbook of Proteolytic Enzymes. 2nd ed. Barrett AJ, Rawlings ND, Woessner JF (Eds), Academic Press, Cambridge, UK.
6. Rawlings, N. D.; Tolle, D. P.; Barrett, A. J. (2004) Evolutionary families of peptidase inhibitors. Biochem. J. 378 , 705-716. (Pubitemid 38406845)
7. Owen, C. A. (2008) Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization. Int. J. Biochem. Cell Biol. 40 , 1246-1272.
8. Stefanidakis, M. and Koivunen, E. (2006) Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood. 108 , 1441-1450. (Pubitemid 44316107)
9. Mohammed, F. F.; Smookler, D. S.; Khokha, R. (2003) Metalloproteinases, Inflammation, and rheumatoid arthritis. Ann Rheum Dis. 62 , ii43.
10. Georges, S.; Ruiz Velasco, C.; Trichet, V.; Fortun, Y.; Heymann, D.; Padrines, M. (2009) Proteases and bone remodeling. Cytokine Growth Factor Review 20 , 29-41.
11. Brooks, P. C.; Strömblad, S.; Sanders, L. C.; von Schalscha, T. L.; Aimes, R. T.; Stetler-Stevenson, W. G.; et al. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin v 3. Cell 85 , 683-693. (Pubitemid 26181048)
12. Redondo-Muñoz, J.; Ugarte-Berzal, E.; García-Marco, J. A.; del Cerro, M. H.; Van den Steen, P. E.; Opdenakker, G.; et al. (2008) 4 1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells. Blood. 112 , 169-178.
13. Dumin, J. A.; Dickeson, S. K.; Stricker, T. P.; Bhattacharyya-Pakrasi, M.; Roby, J. D.; Santoro, S. A.; et al. (2001) Pro-collagenase-1 (matrix metalloproteinase-1) binds the 21 integrin upon release from keratinocytes migrating on type I collagen. J. Biol. Chem. 276 , 29368-29374.
14. Knauper, V.; Will, H.; Lopez-Otin, C.; Smith, B.; Atkinson, S. J.; Stanton, H.; et al. (1996) Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem. 271 , 17124-17131. (Pubitemid 26244262)
15. Nagase, H. (1998) Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res. 8 , 179-186. (Pubitemid 128544278)
16. Yu, W. H. and Woessner, J. F. (2000) Heapran sulphate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J. Biol. Chem. 275 , 4183-4191.
17. Nabeshima, K.; Inoue, T.; Shimao, Y.; Sameshima, T. (2002) Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol. Int. 4 , 255-264. (Pubitemid 34587810)
18. Ryu, H. Y.; Lee, J.; Yang, S.; Par, H.; Cho, S.; Jung, K. C.; et al. (2009) Syndecan-2 Functions as a Docking Receptor for Pro-matrix Metalloproteinase-7 in Human Colon Cancer Cells. J. Biol. Chem. 284 , 35692-35701.
19. Bartolazzi, A.; Nocks, A.; Aruffo, A.; Spring, F.; Stamenkovic, I. (1996) Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Bio l. 132 , 1199-1208. (Pubitemid 26105505)
20. Yu, W. H.; Woessner, J. F.; McNeish, J. D.; Stamenkovic, I. (2002) CD44 anchors the assembly of matrilysin/MMP-7 with heparinbinding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodelling. Genes Dev. 16 , 307-323. (Pubitemid 34111411)
21. Yu, Q. and Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-and promotes tumor invasion and angiogenesis. Genes Dev. 14 , 163-176. (Pubitemid 30070982)
22. Owen, C. A.; Hu, Z.; Lopez-Otin, C.; Shapiro, S. D. (2004) Membrane-bound matrix metalloproteinase-8 activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J. Immunol. 172 , 7791-7803. (Pubitemid 38747647)
23. Davis, G. E.; Pintar Allen, K. A.; Salazar, R.; Maxwell, S. A. (2001) Matrix metalloproteinase-1 and-9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J. Cell Sci. 114 , 917-930.
24. Crabbe, T.; Ioannou, C.; Docherty, A. J. (1993) Human progelatinase A can be activated by autolysis at a rate that is concentrationdependent and enhanced by heparin bound to the C-terminal domain. Eur J Biochem. 218 , 431-438. (Pubitemid 24003757)
25. Sørensen, H. P.; Vives, R. R.; Manetopoulos, C.; Albrechtsen, R.; Lydolph, M. C.; Jacobsen, J.; et al. (2008) Heparan sulfate regulates ADAM12 through a molecular switch mechanism. J Biol Chem. 283 , 31920-31932.
26. Iida, J.; Wilhelmson, K. L.; Ng, J.; Lee, P.; Morrison, C.; Tam, E.; et al. (2007) Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A) Biochem. J. 403 , 553-563. (Pubitemid 46706984)
27. Naito, S.; Shiomi, T.; Okada, A.; Kimura, T.; Chijiiwa, M.; Fujita, Y.; et al. (2007) Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage. Pathol Int. 57 , 703-711. (Pubitemid 47537631)
28. Mort, J. S.; Flannery, C. R.; Makkerh, J.; Krupa, J. C.; Lee, E. R. (2003) Use of antineoepitope antibodies for the analysis of degradative events in cartilage and the molecular basis for neoepitope specificity. Biochem. Soc. Symp. 70 , 107-114. (Pubitemid 38497219)
29. Stanton, H.; Rogerson, F. M.; East, C. J.; Golub, S. B.; Lawlor, K. E.; Meeker, C. T.; et al. (2005) ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434 , 648-652. (Pubitemid 40488557)
30. Gendron, C.; Kashiwagi, M.; Lim, N. H.; Enghild, J. J.; Thøgersen, I. B.; Hughes, C.; et al. (2007) Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J. Biol.Chem. 282 , 18294-18306. (Pubitemid 47100219)
31. Gao, G.; Plaas, A.; Thompson, V. P.; Jin, S.; Zuo, F.; Sandy, J. D. (2004) ADAMTS4 (Aggrecanase-1) Activation on the Cell Surface Involves C-terminal Cleavage by Glycosylphosphatidyl Inositol-anchored Membrane Type 4-Matrix Metalloproteinase and Binding of the Activated Proteinase to Chondroitin Sulfate and Heparan Sulfate on Syndecan-1. J. Biol. Chem. 279 , 10042-10051. (Pubitemid 38372607)
32. Echtermeyer, F.; Bertrand, J.; Dreier, R.; Meinecke, I.; Neugebauer, K.; Fuerst, M.; et al. (2009) Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med. 15 , 1072-1076.
33. Munesue, S.; Yoshitomi, Y.; Kusano, Y.; Koyama, Y.; Nishiyama, A.; Nakanishi, H.; et al. (2007) A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis. J Biol Chem. 282 , 28164-28174. (Pubitemid 47529519)
34. Nakada, M.; Yamada, A.; Takino, T.; Miyamori, H.; Takahashi, T.; Yamashita, J.; et al. (2001) Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Cancer Res. 61 , 8896-8902. (Pubitemid 34013906)
35. Nakada, M.; Miyamori, H.; Yamashita, J.; Sato, H. (2003) Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins. Cancer Res. 63 , 3364-3369. (Pubitemid 36735896)
36. Schmitt, M.; Jaenicke, F.; Graeff, H. (1992) Tumor-associated proteases. Fibrinol. Proteol. 6 , 3-26.
37. Cavallo-Medved, D. and Sloane, B.F. (2003) Cell surface cathepsin B: understanding its functional significance. Curr. Top. Dev. Biol. 54 , 313-341. (Pubitemid 137639473)
38. Podobnik, M.; Kuhelj, R.; Turk, V.; Turk, D. (1997) Crystal structure of the wild-type human procathepsin B at 2.5 A resolution reveals the native active site of a papain-like cysteine protease zymogen. J. Mol. Biol. 271 , 774-788. (Pubitemid 27376053)
39. Turk, V.; Turk, B.; Turk, D. (2001) Lysosomal cysteine proteases: facts and opportunities. EMBO J. 20 , 4629-4633. (Pubitemid 32848615)
40. Turk, B.; Turk, D.; Turk, V. (2000) Lysosomal cysteine proteases: more than scavengers. Biochim Biophys Acta. 1477 , 98-111. (Pubitemid 30119895)
41. Pungercar, J. R.; Caglic, D.; Sajid, M.; Dolinar, M.; Vasiljeva, O.; Pozgan, U.; et al. (2009) Autocatalytic processing of procathepsin B is triggered by proenzyme activity. FEBS J. 276 , 660-668.
42. Caglic, D.; Pungercar, J. R.; Pejler, G.; Turk, V.; Turk, B. (2007) Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions. J. Biol. Chem. 282 , 33076-33085. (Pubitemid 350159276)
43. Beckman, M.; Freeman, C.; Parish, C. R.; Small, D. H. (2009) Activation of cathepsin D by glycosaminoglycans. FEBS J. 276 , 7343-7352.
44. Klaver, D. W.; Wilce, M. C. J.; Gasperini, R.; Freeman, C.; Juliano, J. P.; Parish, C.; et al. (2010) Glycosaminoglycan-induced activation of the secretase (BACE-1) of Alzheimers disease. J Neurochem. 112 , 1552-1561.
45. Sinha, S.; Anderson, J. P.; Barbour, R.; Basi, G. S.; Caccavello, R.; Davis, D.; et al. (1999) Purification and cloning of amyloid precursor protein beta secretase from human brain. Nature 402 , 537-540.
46. Scholefi eld, Z.; Yates, E. A.; Wayne, G.; Amour, A.; McDowell, W.; Turnbull, J. E. (2003) Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimers beta-secretase. J. Cell Biol. 163 , 97-107. (Pubitemid 37271437)
47. Hogg, P. J. and Jackson, C. M. (1990) Heparin promotes the binding of thrombin to fi brin polymer. Quantitative characterization of a thrombin-fi brin polymer-heparin ternary complex. J. Biol. Chem. 265 , 241-247. (Pubitemid 20032335)
48. Stein, P. L.; van Zonneveld, A. J.; Pannekoek, H.; Strickland, S. (1989) Structural domain of tissue-type plasminogen activator that confer stimulation by heparin. J. Biol. Chem. 264 , 15441-15444. (Pubitemid 19242917)
49. Frommherz, K. J.; Faller, B.; Bieth, J. G. (1991) Heparin strongly decreases the rate of inhibition of neutrophil elastase by 1-proteinase inhibitor. J. Biol. Chem. 266 , 15356-15362. (Pubitemid 21907655)
50. Fryer, A.; Huang, Y. C.; Rao, G.; Jacoby, D.; Mancilla, E.; Whorton, R.; et al. (1997) Selective O-desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung. J. Pharmacol. Exp.Ther. 282 , 208-219. (Pubitemid 27425543)
51. Spencer, J. L.; Stone, P. J.; Nugent, N. A. (2006) New Insights into the Inhibition of Human Neutrophil Elastase by Heparin. Biochemistry 45 , 9104-9120. (Pubitemid 44156373)
52. Moreau, T.; Baranger, K.; Dadé, S.; Dallet-Choisy, S.; Guyot, N.; Zani, M. L. (2008) Multifaceted roles of human elafi n and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie 90 , 284-295. (Pubitemid 351172573)
53. Cadne, M.; Boudier, C.; Marcillac, G. D.; Bieth, J. G. (1995) Influence of low molecular mass heparin on the kinetics of neutrophil elastase inhibition by mucus proteinase inhibitor. J. Biol.Chem. 270 , 13204-13209.
54. Ermolieff, J.; Duranton, J.; Petitou, M.; Bieth, J. (1998) Heparin accelerates the inhibition of cathepsin G by mucus proteinase inhibitor: potent effect of O-butyrylated heparin. Biochem. J. 330 , 1369-1374. (Pubitemid 28162017)
55. Walter, M.; Plotnick, M.; Schechter, N. M. (1996) Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin. Arch. Biochem. Biophys. 327 , 81-88 (Pubitemid 26063736)
56. Stein, P. E. and Carrell, R. W. (1995) What do dysfunctional serpins tell us about molecular mobility and disease? Nat. Struct. Biol. 2 , 96-113. (Pubitemid 26040647)
57. Stratikos, E. and Gettins, P. G. W. (1999) Formation of the covalent serpine proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into sheet A. Proc. Natl. Acad. Sci. USA. 96, 4808-4813. (Pubitemid 29214493)
58. Gettins, P. G. W. (2002) Serpin structure, mechanism and function. Chem. Rev. 102 , 4751-4803.
59. Desai, U. R.; Petitou, M.; Björk, I.; Olson, S. T. (1998) Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites. Biochemistry 37 , 13033-13041. (Pubitemid 28433538)
60. Gupta, V. K. and Gowda, L.R. (2008) Alpha-1-proteinase inhibitor is a heparin binding serpin: molecular interactions with the Lys richcluster of helix-F domain. Biochimie 90 , 749-761.
61. Higgins, W. J.; Fox, D. M.; Kowalski, P.S.; Nielsen, J. E.; Worrall, D. M. (2010) Heparin enhances serpin inhibition of the cysteine protease cathepsin L. J. Biol. Chem. 285 , 3722-3729.
62. Murphy, G.; Knäuper, V.; Lee, M. H.; Amour, A.; Worley, J. R.; Hutton, M.; et al. (2003) Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. Biochem. Soc. Symp. 70 , 201-212.
63. Amour, A.; Slocombe, P. M.; Webster, A.; Butler, M.; Knight, C. G.; Smith, B. J.; et al. (1998) TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435 , 39-44. (Pubitemid 28432011)
64. Smith, M. R.; Kung, H. F.; Durum, S. K.; Colburn, N. H.; Sun, Y. (1997) TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine 9 , 770-780. (Pubitemid 27477722)
65. Lee, M. H.; Atkinson, S.; Murphy, G. (2007) Identification of the extracellular matrix (ECM) binding motifs of tissue inhibitor of metalloproteinases (TIMP)-3 and effective transfer to TIMP-1. J. Biol. Chem. 282 , 6887-6898. (Pubitemid 47100842)
66. Butler, G. S.; Apte, S. S.; Willenbrock, F.; Murphy, G. (1999) Human tissue inhibitor of metalloproteinases 3 interacts with both the N-and C-terminal domains of gelatinases A and B. Regulation by polyanions. J. Biol. Chem. 274 , 10846-10851.
67. Turk, B.; Bieth, J. G.; Björk, I.; Dolenc, I.; Turk, D.; Cimerman, N.; et al. (1995) Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins. Biol. Chem. Hoppe Seyler 376 , 225-230.
68. Yan, S. and Sloane, B. F. (2004) Molecular regulation of human cathepsin B: implication in pathologies. Biol. Chem. 384 , 845-854.
69. Sloane, B. F.; Rozhin, J.; Lah, T. T.; Day, N.A.; Buck, M.; Ryan, R. E.; et al. (1988) Tumor cathepsin B and its endogenous inhibitors in metastasis. Adv. Exp. Med. Biol. 233 , 259-268
70. Almeida, P. C.; Nantes, I. L.; Chagas, J. R.; Rizzi, C. C.; Faljoni-Alario, A.; Carmona, E.; et al. (2001) Cathepsin B activity regulation heparin-like glycosaminoglycans protect human cathepsin B from alkaline ph-induced inactivation. J. Biol. Chem. 276 , 944-951. (Pubitemid 32096513)
71. Almeida, P. C.; Nantes, I. L.; Rizzi, C. C. A.; Jdice, W. A.; Chagas, J. R.; Juliano, L.; et al. (1999) Cysteine proteinase activity regulation. A possible role of heparin and heparin-like glycosaminoglycans. J. Biol. Chem. 274 , 30433-30438.
72. Littlewood-Evans, A.; Kokubo, T.; Ishibashi, O.; Inaoka, T.; Wlodarski, B.; Gallagher, J. A.; et al. (1997) Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 20 , 81-86. (Pubitemid 27086994)
73. Li, Z.; Hou, W. S.; Escalante-Torres, C. R.; Geld, B. D.; Bromme, D. (2002) Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate. J Biol Chem 277 , 28669-28676.
74. Li, Z.; Yasuda, Y.; Li, W.; Bogyo, M.; Katz, N.; Gordon, R. E.; et al. (2004) Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J. Biol. Chem. 279 , 5470-5479. (Pubitemid 38220571)
75. Novinec, M.; Kovacic, L.; Lenarcic, B.; Baici, A. (2010) Conformational fl exibility and allosteric regulation of cathepsin K. Biochem. J. 429 , 379-389.